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Abstract 
Objectives: Oral lichen planus is chronic inflammatory disease with a high prevalence in the population. This study 
describes the epidemiological and clinical characteristics of group of patients with oral lichen planus in the Czech 
Republic.
Material and Methods: Data was taken from the medical records of 171 patients referred to the Oral Medicine Unit 
at the University Hospital in Hradec Králové with histologically confirmed clinical diagnosis of oral lichen planus 
in the period 2003 – 2013. The data were retrospectively reviewed. 
Results: Of the 171 patients, 116 (67.8%) were women and 55 (32.2%) were men. The mean age was 55.2 ± 12.4 
years (range of 85.0 – 20.9). The reticular form was the most frequent 93.6% (160 pts.), desquamative gingivitis 
was 12.9% (22). The buccal mucosa was the site most affected 89.5% (153 pts.). The lesions were asymptomatic 
in 52 patients (30.4%). Extraoral lesions were observed in 20.5% (35 pts.) of the patients, skin involvement was in 
16.4% (28 pts.). Smokers were 29 patients. Local treatment used 116 (67.8%), only 6 patients used systemic short 
tome corticoid therapy. No evidence between OLP and malignant transformation was observed. 
Conclusions: This retrospective study show very similar profile and clinical features of the patients with OLP as in 
other studies.  
Key words: Oral lichen planus, clinical features, extraoral manifestation.
doi:10.4317/jced.51784
http://dx.doi.org/10.4317/jced.51784
Article Number: 51784                http://www.medicinaoral.com/odo/indice.htm
© Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488
eMail:  jced@jced.es
Indexed in:
Pubmed
Pubmed Central® (PMC)
Scopus
DOI® System
Radochová V, Dřízhal I, Slezák R. A retrospective study of 171 patients 
with oral lichen planus in the East Bohemia - Czech Republic – single 
center experience. J Clin Exp Dent. 2014;6(5):e556-61.
http://www.medicinaoral.com/odo/volumenes/v6i5/jcedv6i5p556.pdf
Introduction
Oral lichen planus (OLP) is chronic inflammatory di-
sorder that affects the oral mucous membrane. It is a 
common disease affecting 0.1% to 4% of the population 
(1-4). The disease usually manifests at the age of 50-70 
years and it is very rare in children (5). The etiology and 
pathogenesis remains unknown but there is overwhel-
ming evidence that cell-mediated immunity is crucial in 
the pathogenesis. Both antigen-specific and non-specific 
mechanisms may be involved in the pathogenesis of oral 
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lichen planus. Antigen-specific mechanisms in OLP in-
clude antigen presentation by basal keratinocytes and 
antigen-specific keratinocyte killing by CD8+ cytotoxic 
T-cells (6). An autoimmune reaction in which CD8+ 
T lymphocytes attack basal keratinocytes and lead to 
apoptosis of the cells has been favored. Various poten-
tial triggers, e.g. viral or bacterial antigens, metal ions, 
drugs or physical factors could initiate the autoimmu-
ne process (7,8). Genetic involvement in OLP is yet to 
be determined. OLP can clinically manifest in different 
forms. Andreasen was the first to classify OLP, and pos-
tulated the existence of six different clinical forms (9). 
Later, this classification was simplified by other authors 
who basically divided the clinical forms of OLP into 
reticular, papular, atrophic and erosive lesions or only 
for red and white forms (5,10). There is often overlap 
between types, with a combination of reticular, erosive 
and erythematous lesions. The presentation varies in cli-
nical appearance, with the most lesions being bilateral 
and located on the buccal mucosa (90%), tongue (30%) 
and gingiva (13%). Occasionally they can be also found 
on the lips and palate (4). Isolated lichen planus may be 
seen in up to 8.6% of patients (11). The patients with 
OLP may develop lesions that affect the skin, nails or 
other mucosal surfaces (12). OLP is diagnosed clinically 
by means of a biopsy for histopathological analysis. The 
classical microscopic features observed in the oral mu-
cosa include hyperorthokeratosis or hyperparakeratosis, 
acanthosis, thickening of the spinous layer, liquefaction 
of the basal layer accompanied by the degeneration of 
keratocytes and lymphocyte infiltration of the lami-
na propria (13). The question of treatment is difficult. 
Treatment should be directed at achieving specific goals 
after considering the degree of clinical involvement, the 
predominant clinical type of lesions and the patient´s 
symptoms. Reticular lesions that are asymptomatic 
generally require no therapy but only observation for 
change (14). In general, all treatment should be aimed at 
eliminating atrophic and ulcerative lesions and allevia-
ting symptoms. In 1978, the World Health Organizations 
classified OLP as a precancerous lesion, i.e., since then 
it has been regarded as a generalized process associated 
with a risk of developing cancer. Although a number of 
studies have analyzed the malignant transformation of 
OLP, such malignization remains the subject of contro-
versy (15). To date, most of the more detailed epidemio-
logical and clinical studies of OLP have been undertaken 
in the other countries but never in the Czech Republic. A 
general similarity has been confirmed in different popu-
lations – including a predilection for women, a mean age 
about fifty years and the buccal mucosa being the most 
predilection site. The aim of this study was to undertake 
a retrospective examination of the general features and 
clinical presentation of a group of Czech patients with a 
clinical and histopathological diagnosis of OLP. 
Patient and Methods 
The study was approved by local Ethics Committee. 
The study group comprises 171 patients examined at 
the Oral Medicine Unit at Department of Dentistry Cli-
nic Charles University in Prague, Faculty of Medicine 
and University Hospital in Hradec Králové in the Czech 
Republic in the period 2003-2013 with histologically 
confirmed clinical diagnosis of OLP according to the 
diagnostic criteria of World health Organization (WHO) 
of 1978 modified by van der Meij et al. in 2003 (16). 
We excluded patients with oral lichenoid contact lesions 
caused by identifiable cause such as a hypersensitivity 
reaction to dental restorative materials or patients with 
lichenoid dysplasia. Only patients with clinical and his-
tological evidence of OLP were included in the study. 
The following clinical data were obtained from the me-
dical charts: gender, age, clinical presentations of OLP, 
distributions of the lesions, presence of the symptoms, 
extraoral manifestations of lichen planus, status of the 
oral hygiene and periodontal health,  presence of syste-
mic diseases, history of the medications, treatment pro-
vided (topical corticosteroid in mucosal adhesive paste 
or as intralesional injection or systemic corticosteroid), 
adverse effects of treatment, tobacco use. We have also 
divided the patients into two groups: the first group 
comprises of the reticular and plaque lesions and second 
group comprises erosive and erythematous lesions. We 
compared the groups for possible clinical differences. A 
descriptive statistical analysis was made using Micro-
soft Excel 2003 (Microsoft, USA) and MedCalc 9.5.2.0 
(MedCalc Software, Belgium). Chi-square and Student 
t-test were used for comparisons. P value < 0.05 was 
considered statistically significant.
Results
-Patient´s gender and ethnic origin: 
A total of 171 charts of patients with confirmed diag-
nosis of OLP were retrospectively analyzed, of whom, 
116/171 (67.8%) were women and 55/171 (32.2%) were 
men, giving a female to male ratio of 2.11:1. All of affec-
ted patients were white Caucasian.
-Age of onset of oral lichen planus: 
 The mean age of the patients at presentations was 55.2 
±12.4 years (mean age for women is 57.0 ± 12.2, for 
men is 51.2 ± 11.8), with an overall range of 85.0 – 20.9 
years. The highest prevalence for women was found in 
the age group 50-59 years (62/171 pts., 36.2%), for men 
in the age group 60-69 (56/171 pts., 32.7%) . Age distri-
bution plot is shown in figure 1.
-Systemic diseases, medication, smoking: 
Positive history for medication and systemic diseases was 
found in 117 patients (68.4%). The most prevalent syste-
mic disorders included arterial hypertension (present in 
83/171 pts., 48.5% of all patients), thyroid gland disor-
ders (25/171 pts., 14.6%), diabetes mellitus (25/171 pts., 
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Fig. 1. Age distribution of patients with OLP.
14.6%), hypercholesterolemia (21/171 pts., 12.3%), other 
cardiovascular diseases (19/171 pts., 11.1%), hypothyroi-
dism (18/171 pts., 10.5%), anxiety/depression (16/171 
pts., 9.4%), rheumatological diseases (9/171 pts., 5.2%) 
and hypeurikemia (8/171 pts., 4.7%). Positive allergy 
history was in 36/171 patients (21.1%). The medications 
taken by the patients are shown in figure 2. Most of the 
patients were non-smokers (142/171 pts., 83%). 
Fig. 2. Consumption of drugs by patients with OLP.
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-Chief symptoms associated with oral lichen planus: 
The presence of the symptoms was reported by the 
109/171 patients (63.7%). Severe sustained pain occu-
rred only in 37/171 (21.6%) patients, mild and mode-
rate pain in 72/171  pts. (42.1%).  Only 3/171 patients 
(3.8%) had severe pain in white forms (reticular a plaque 
lesions), 34/171 patients (37.0%) in red forms (erosive 
and erythematous lesions). Comparison of erythema-
tous and erosive forms (red lesions) versus the others is 
shown in table 1.
Table 1. Comparison of patients with red versus white forms of OLP.
Statistics done by chi-square test, p<0.05 considered significant
-Clinical types of oral lichen planus and distribution:  
The most common type was reticular form of the oral li-
chen planus which was observed in 160/171 (93.5%) pa-
tients. 11/171 (6.4%) patients did not show any reticula 
and were presented only by other clinical forms without 
reticula. Erosive form was the second most common 
type with a prevalence of 80/171 (46.8%) pts. Prevalen-
ce of the erythematous lesions was 66/171(38.6%) and 
plaque form was in 56/171 (32.7%) pts. Desquamative 
gingivitis was present in 22/171 (12.9%) pts. In all cases 
of desquamation, there was a combination with another 
form of OLP. 107/171 patients (62.6%) had combination 
of more types of OLP. 
Most of the patients (126/171, 73.7%) exhibited multiple si-
tes of involvement, with the buccal mucosa being the most 
common location in each clinical form (153/171, 89.5%), 
followed by the  tongue (93/171, 54.4%), gingiva and al-
veolar mucosa (44/171, 25.7%), lips (32/171, 18.7%). Le-
sions on the palate (8/171, 4.7%) and floor of the mouth 
(6/171, 3.5%) were uncommon. No malignant transforma-
tion was observed during the observation period.
-Extraoral manifestaion:
Extraoral lesions were observed in 20.5% (35/171 pa-
tients) of the patients, skin problems were in 16.4% 
Red forms % White forms % p value
Number of patients N=92  53.8 N=79 46.2   
Patient´s history N % N % 
Hypertension 46 50,0 37 46,8 0.6798 
Dibetes mellitus 16 17,4 9 11,4 0.2683 
Other cardiovascular 11 12,0 8 10,1 0.7042 
Psychiatric disorders 10 10,9 6 7,6 0.4635 
Hypothyroidism 17 18,5 8 10,1 0.1233 
Allergies 19 20,7 17 21,5 0.8898 
Smokers 15 16,3 14 17,7 0.8055 
Lesion distribution N % N % 
Buccal  82 89,1 71 89,9 0.8746 
Lip 23 25,0 9 11,4 0.0229 
Tongue 62 67,4 31 39,2 0.0002 
Palate 7 7,6 1 1,3 0.0502 
Alveolar ridge 30 32,6 14 17,7 0.0264 
Bottom of oral cavity 6 6,5 1 1,3 0.0837 
Symptoms N % N % 
Severe pain 34 37,0 3 3,8 <0.0001
Mild pain 59 64,1 50 63,3 0.9094 
Recurring 51 55,4 10 12,7 <0.0001
Need of treatment N % N % 
Any 90 97,8 33 41,8 <0.0001
Topical 88 95,7 28 35,4 <0.0001
Intralesional 56 60,9 5 6,3 <0.0001
Systemic 6 6,5 0 0,0 0.0208 
?
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(28/171 patients). Another 7/171 patients (4%) had ge-
nital involvement or the involvement of nails.
-Treatment: 
Topical steroids alone were prescribed to 116/171 
(67.8%) and in combination with systemic steroids to 
6/171 (3.5%) of the patients. 55/171 (32.2%) patients 
didn´t use the drugs (asymptomatic or the symptoms 
were very small). In the local treatment we used dexame-
thasone gel, which patients applied a several times per 
day to the most symptomatic areas. In 61/171 (35.7%) 
cases we used combination dexamtehasone gel and de-
pot form of corticosteroid intralesional.    
Discussion
This is as we know the first retrospective analysis of 
patients with OLP conducted in the east Bohemia. As 
all retrospective data, it has its major limitations. The 
biggest bias could potentially be produced by the fact, 
that our hospital is a tertiary care facility and there is 
a possibility, that not all the patients from the general 
practitioners are reported. In general, the results of the 
present study of OLP are compatible with other previous 
studies, but we also found some differences which are 
a matter for discussion. In our study the women were 
affected in 67.8%, representing the ratio 2.1:1. This 
number of affected women is similar to the one showed 
the other studies published by (17). The first manifesta-
tion of OLP is usually between 50 and 70 years of age. 
Our mean age (55.2 years) is similar to that reported by 
the most of the authors. In the series of 690 patients from 
UK, reported mean age was 52 years (18). There was a 
tendency for all types of OLP to occur in male patients 
at an earlier age than in females. However on the other 
hand, the highest prevalence in males was between 60-
69 years of age. There is also another observation nee-
ding attention in our data. We found a small incidence 
peak in the female group in the age 30-39 years. The 
precise reasons for this are unknown and probably not 
of clinical or etiological significance. We think that pos-
sible socioeconomic and stress factors may play a role. 
The coincidence of all systemic diseases is 68.4%. Arte-
rial hypertension is present in 48.5%. It is higher number 
than for example in Italian study of 808 patients (20% 
of hypertension) or Spanish study of 550 cases (23% of 
hypertension) (19,20), but only slightly higher compa-
red to population data in the Czech Republic. For exam-
ple regarding hypertension there is a general prevalence 
of hypertension in the Czech Republic about 40% and 
even higher (60-70%) in patients above the age of 60 
(21). Diabetes is also highly prevalent in our population 
(about 10%) (22) and our data (14.6% of patients with 
OLP) exceed this number only slightly. Our data show 
even smaller prevalence of rheumatological diseases, 
anxiety and depression compared to the previously men-
tioned studies. We have observed about 10% of patients 
with hypothyroidism in our group. Recent publication 
by Robledo-Sierra (23) suggested potential association 
between OLP and hypothyroidism. The association of 
these two disorders may not be incidental since both di-
sorders are generally accepted as autoimmune and might 
share some pathogenetic mechanisms. Extraoral lesions 
were observed in 20.5 % of the patients. This is com-
parable to other reported resources such as data from 
Eisen (24). The intraoral clinical presentation regarding 
distribution of the lesions is quite the same as reported 
many times previously (25). All patients have bilateral 
lesions. Erosive and erythematous OLP (red lesions) 
represent more than half (53.8%) of the patients. This 
number of patients is higher compared to series repor-
ted previously. In Romanian study by Tovaru (26), there 
were only 35.8% of red forms and in Brazilian study by 
Oliveira Alves 41.8% of red forms were reported (27). 
On the other hand in Turkish study by Gümrü (28), the-
re was a predominance of red forms similar to ours (60 
%). As would be expected, the red lesions produce much 
more clinical problems than the white ones. We could 
clearly show that red lesions require treatment more fre-
quently than white lesions and also require more often 
systemic treatment. In our series, the need for topical 
treatment for serious symptoms was required in 98% 
of patients with red lesions where only 44% of patients 
with white lesions required any therapy (p<0.0001). 
Also considering systemic treatment with steroids, all 
6 patients who received oral steroid therapy were from 
the red lesion group (p=0.02). The same is true for in-
tralesional application of corticoids. The patients with 
red lesions were treated with intralesional application in 
61% of cases, where only 6% of patients with white le-
sions required this procedure (p<0.0001). There is also 
an interesting fact regarding the distribution of lesions in 
the oral cavity. Red lesions are more frequently found on 
less common places especially palate and alveolar ridge 
(p=0.05, p=0.03). Also the recurrence of symptoms af-
ter treatment is much higher in red lesions than in whi-
te lesions (55% vs. 13%, p<0.0001). From this point of 
view it is clear that occurrence of red lesion is related 
to clinically much more aggressive behavior and need 
for further treatment. We have not observed any malig-
nant transformation of OLP in our group of patients. We 
have to admit that the period of follow up is relatively 
short and it cannot be excluded that such event might 
occur in the future. Given the fact, that about 0.5–2% 
patients with longstanding oral lichen planus may deve-
lop a squamous cell carcinoma (29), the periodic obser-
vation of these lesions for dysplastic changes remains 
prudent. However given the very small chance for oral 
cancer, the real potential for malignant transformation of 
lichen planus remains controversial. Especially the cost 
benefit of frequency of following check-up remains an 
unresolved problem. The fact of carrying a potentially 
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malignant disease must be explained to the patients in 
great detail, given the fact that only the minority of pa-
tient might develop cancer during many years. Having 
reviewed all the data we came to the conclusion, that 
Czech population with OLP behaves in very similar pat-
tern as previously published with minor differences of 
discutable significance. 
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